© Copyright 2026 American Medical Association. All rights reserved.
The Caffeine Halothane Contracture Test (CHCT) is a specialized laboratory procedure designed to assess an individual's susceptibility to malignant hyperthermia (MH). Malignant hyperthermia is a rare but potentially fatal condition that can be triggered by certain anesthetic agents, particularly volatile anesthetics and neuromuscular blocking agents used during general anesthesia. The underlying mechanism of MH involves a rapid and uncontrolled increase in oxidative metabolism within striated skeletal muscle, which is primarily due to abnormal calcium handling within muscle cells. This condition can lead to severe physiological disturbances, including muscle rigidity, elevated body temperature, tachycardia, increased carbon dioxide production, decreased oxygen levels, and acidosis, all resulting from hyper-metabolic activity in the muscle tissue. Symptoms of MH may manifest as rigidity of the masseter muscle or generalized muscle stiffness, alongside other critical signs such as elevated body temperature and altered blood gas levels. Additionally, the breakdown of muscle tissue, known as rhabdomyolysis, can occur, leading to the release of myoglobin into the bloodstream, which poses a risk of acute kidney injury and cardiac complications. Individuals at risk for malignant hyperthermia may have a family history of the condition, previous unexplained fevers, episodes of rhabdomyolysis, or symptoms such as dark-colored urine or heat stroke. The CHCT involves obtaining a sample of striated muscle tissue through a biopsy, which is a separately reportable procedure. The fresh muscle fibers are then subjected to electrical stimulation in a controlled environment, and their contraction responses are measured. Following this, the muscle fibers are exposed to ryanodine receptor agonists, specifically caffeine and halothane, to evaluate their contractile response. A significant increase in muscle contraction force in response to these agents indicates a high likelihood of malignant hyperthermia susceptibility. The CPT® Code 89049 encompasses the entire process, including the pathologist's review of patient records, the interpretation of test results, and the generation of a comprehensive written report detailing the findings.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.